5.82

16.40% 0.82

After Hours: 5.80 -0.02 -0.34%

Sight Sciences Inc (SGHT)

Overview News Price History Option Chain Financials Why SGHT Down? Discussions Forecast

Sight Sciences Inc stock is traded at $5.82, with a volume of 285.22K. It is up +16.40% in the last 24 hours and up +67.72% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Previous Close:

$5.00

Open:

$5.49

24h Volume:

285.22K

Relative Volume:

1.98

Market Cap:

$304.78M

Revenue:

$81.06M

Net Income/Loss:

$-55.55M

P/E Ratio:

-5.1053

EPS:

-1.14

Net Cash Flow:

$-47.98M

1W Performance:

+15.02%

1M Performance:

+67.72%

6M Performance:

+103.50%

1Y Performance:

+24.36%

1-Day Range:

$5.38

$5.86

1-Week Range:

$4.86

$5.86

52-Week Range:

$2.03

$5.86

Sight Sciences Inc Stock (SGHT) Company Profile

Name

Sight Sciences Inc

Sector

Healthcare (1134)

Industry

Medical Devices (144)

Phone

(415) 889-0550

Address

4040 CAMPBELL AVE,, MENLO PARK

Employee

216

Twitter

Next Earnings Date

2025-03-05

Latest SEC Filings

SGHT's Discussions on Twitter

Compare SGHT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGHT Sight Sciences Inc	5.82	261.84M	81.06M	-55.55M	-47.98M	-1.14
ABT Abbott Laboratories	126.36	217.27B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	100.02	146.84B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	356.03	135.31B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	92.20	115.51B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	83.39	47.84B	5.88B	1.34B	799.60M	2.3489

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-08-25	Upgrade	Lake Street	Hold → Buy
Dec-06-24	Initiated	UBS	Buy
Nov-04-24	Downgrade	Lake Street	Buy → Hold
Aug-21-24	Initiated	Lake Street	Buy
Sep-12-23	Downgrade	BofA Securities	Neutral → Underperform
Sep-12-23	Downgrade	Piper Sandler	Overweight → Neutral
Sep-12-23	Downgrade	William Blair	Outperform → Mkt Perform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-10-23	Downgrade	Citigroup	Buy → Neutral
Jan-06-23	Upgrade	Stifel	Hold → Buy
Oct-04-22	Initiated	Needham	Hold
Jul-26-22	Initiated	Stifel	Hold
Feb-03-22	Initiated	William Blair	Outperform
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Sight Sciences Inc Stock (SGHT) Latest News

Nov 08, 2025

Why Sight Sciences Inc. stock remains undervaluedSell Signal & Growth Focused Entry Reports - newser.com

Nov 08, 2025

How Recent Developments Are Changing The Sight Sciences Investment Story - Yahoo Finance

Nov 08, 2025

Nov 07, 2025

Sight Sciences’ Earnings Call: Mixed Sentiment and Strategic Advances - TipRanks

Nov 07, 2025

Piper Sandler Maintains Sight Sciences (SGHT) Neutral Recommendation - Nasdaq

Nov 07, 2025

Market reaction to Sight Sciences Inc.’s recent newsWeekly Profit Recap & Smart Allocation Stock Tips - newser.com

Nov 07, 2025

Candlestick signals on Sight Sciences Inc. stock today2025 Price Momentum & Weekly High Potential Alerts - newser.com

Nov 07, 2025

Sight Sciences stock holds steady as Needham maintains rating - Investing.com

Nov 07, 2025

Sight Sciences Q3 2025 Earnings Call Transcript - MarketBeat

Nov 07, 2025

Sight Sciences appoints new COO and CFO in leadership overhaul By Investing.com - Investing.com Canada

Nov 07, 2025